Ryan Specialty (NYSE:RYAN - Get Free Report) is anticipated to issue its Q1 2025 quarterly earnings data after the market closes on Thursday, May 1st. Analysts expect Ryan Specialty to post earnings of $0.40 per share and revenue of $680.80 million for the quarter.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Ryan Specialty Stock Performance
Shares of Ryan Specialty stock traded down $1.45 on Tuesday, reaching $63.94. 306,093 shares of the stock were exchanged, compared to its average volume of 1,028,908. Ryan Specialty has a 1-year low of $48.85 and a 1-year high of $77.16. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The business has a fifty day moving average price of $70.35 and a two-hundred day moving average price of $68.88. The firm has a market capitalization of $16.74 billion, a PE ratio of 92.49, a PEG ratio of 1.19 and a beta of 0.66.
Ryan Specialty Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.75%. The ex-dividend date was Tuesday, March 4th. Ryan Specialty's dividend payout ratio is presently 69.57%.
Analysts Set New Price Targets
Several brokerages recently issued reports on RYAN. Royal Bank of Canada reduced their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Wells Fargo & Company cut their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. TD Cowen initiated coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target on the stock. UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Finally, Keefe, Bruyette & Woods cut their price target on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $75.67.
Check Out Our Latest Analysis on Ryan Specialty
Insiders Place Their Bets
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the transaction, the director now owns 2,697 shares of the company's stock, valued at approximately $177,031.08. The trade was a 92.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.
About Ryan Specialty
(
Get Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.